NovoCure (NVCR) Times Interest Earned (2014 - 2026)
NovoCure (NVCR) posted quarterly Times Interest Earned of -$1.94 for Q2 2026, up 86.16% year-on-year from -$1.04 in Q2 2025, and up 84.58% on a QoQ basis from -$12.55 in Q1 2026.
NovoCure (NVCR) Times Interest Earned (2014 - 2026) Analysis & Trends
NovoCure (NVCR) has reported Times Interest Earned for 13 consecutive years, with -$1.94 the latest figure, recorded in Q2 2026.
- Quarterly Times Interest Earned rose 86.16% year-over-year to -$1.94 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$7.78 (up 49.01% YoY) and the FY2025 annual result came in at -$0.08, up 19.46% from the prior year.
- Times Interest Earned rose to -$1.94 in Q2 2026 per NVCR's latest filing, from -$12.55 in the prior quarter.
- Over the last five years, Times Interest Earned for NVCR reached as high as -$0.47 in Q1 2022 and fell as low as -$20760.0 in Q1 2024.
- A 5-year average of -$1312.6 and a median of -$12.35 in 2026 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned sank 27982.46% — and 2025, when it surged 99.93%.
- Year by year, Times Interest Earned stood at -$5.3 in 2022, then sank by 98.92% to -$10.54 in 2023, then slumped by 134.12% to -$24.68 in 2024, then soared by 72.98% to -$6.67 in 2025, then jumped by 70.97% to -$1.94 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$1.94, -$12.55, and -$6.67 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | 1.19 |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | 5.36 |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 82.35 |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | -2.90 |
| 10 | NovoCure | 2.07 Bn | 1.63 Bn | 142.48 Mn | -1.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.94 |
| Mar 31, 2026 | -12.55 |
| Dec 31, 2025 | -6.67 |
| Sep 30, 2025 | -12.14 |
| Jun 30, 2025 | -13.99 |
| Mar 31, 2025 | -13.57 |
| Dec 31, 2024 | -24.68 |
| Sep 30, 2024 | -10.20 |
| Jun 30, 2024 | -17.05 |
| Mar 31, 2024 | -20,760.00 |
| Dec 31, 2023 | -10.54 |
| Mar 31, 2023 | -73.93 |
| Dec 31, 2022 | -5.30 |
| Sep 30, 2022 | -29.62 |
| Jun 30, 2022 | -9.48 |
| Mar 31, 2022 | -0.47 |
| Dec 31, 2021 | -2.65 |
| Sep 30, 2021 | -4.32 |
| Jun 30, 2021 | -12.60 |
| Mar 31, 2021 | -0.03 |